August 2021 Fortune magazine continues to rank the largest companies in Turkey, just as it does in the United States, based on annual net turnover, exports, and profitability before tax, etc. Ali Raif İlaç continues its steady climb on the Fortune 500 List, which saw its 14th instalment this year. The Fortune 500 list includes […]
- Login / Register
- 0 items - ₺0.00
- English
The Company Aims to Quadruple its Production Capacity Established in 1928, Ali Raif İlaç Sanayi has a deep-rooted history and an important place in the Turkish pharmaceutical industry with its 58 years of experience in the field. The company has now taken an important step in line with its growth targets and broke ground for […]
Ali Raif İlaç R&D Director Serdar Ünlü, Ph.D., answering the questions from Fortune magazine’s special issue on R&D, emphasized that the only way to shape the future of the Turkish pharmaceutical industry and have a presence in global markets is to engage in innovative R&D efforts and undertake the correct management of industrial rights that […]
As a company whose mission for 58 years has been to provide high-quality services and products that protect and improve human health, Ali Raif İlaç was awarded the grand prize in the Pharmaceutical Company With the Most Brands in the R&D Center category at the 9th International Pharmaceutical Chemistry Congress R&D Awards. After engaging in […]
Ali Raif İlaç Sanayi, a 57-year pharmaceutical company serving the Turkish healthcare industry, has undergone a change of management. Serving as a General Manager for 32 years, Muzaffer Bal handed over to Nihal Arslan, who has been working in various positions at the company since 1990 and has been the Deputy General Manager of Marketing […]